Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
511.08 Up 4.57(0.90%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:506.51
Open:509.50
Bid:496.51 x 100
Ask:513.00 x 100
1y Target Est:511.71
Beta:0.71
Earnings Date:Aug 3 - Aug 7 (Est.)
Day's Range:505.29 - 512.50
52wk Range:295.76 - 544.00
Volume:374,932
Avg Vol (3m):752,298
Market Cap:53.79B
P/E (ttm):163.97
EPS (ttm):3.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 0.90%53.79B
AMGNDown 1.12%116.53B
NVSUp 1.30%241.55B
RHHBYUp 0.09%N/A

Key Statistics

Forward P/E (1 yr):38.00
P/S (ttm):16.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :11.17
Quarterly EPS Est (Jun-15) :2.78
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.28

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback